Fake Cancer Drugs; Let’s Talk About Sex; Reducing Cancer-Related Fatigue

Beware of fake cancer drugs that have found their way into the booming online business of counterfeit prescription medications. (Roswell Park Comprehensive Cancer Center)

Cecile Richards, 67, former president of Planned Parenthood and long-time abortion-rights activist, died of brain cancer earlier this week. (The Guardian)

Clinicians often do not discuss sex with cancer survivors, but patients wish they would. (NPR)

Two negative studies in non-small cell lung cancer have some cancer experts questioning TIGIT as a valid therapeutic target. (European Society for Medical Oncology)

Chemoablation with mitomycin gel (Jelmyto) for low-grade upper tract urothelial cancer led to a 3-year recurrence-free survival of 68% in responding patients, UroGen Pharma announced.

Digoxin, one of the oldest heart medications, has shown potential for dissolving circulating tumor cells to prevent metastases, ETH Zürich announced.

An interim analysis of a phase III trial in acute myeloid leukemia suggested a potential doubling of overall survival versus historical controls with the peptide cancer vaccine galinpepimut-S (GPS), Sellas Life Sciences announced.

A telephone-based behavioral intervention showed promise for reducing fatigue in breast cancer survivors. (Regenstrief Institute)

Research that characterized differences in the immune system of children versus adults could pave the way for new precision treatments for pediatric malignancies. (Karolinska Institute)

Studies in mice showed complete clearance of breast cancers after a single dose of an investigational drug designed to kill cancer cells but avoid undesirable side effects. (American Chemical Society)

Two drugs that target HER2 expression in cancer — tucatinib (Tukysa) and trastuzumab (Herceptin) — led to tumor shrinkage in 42% of women with previously treated HER2-negative breast cancer associated with specific types of HER2 mutations. (University of Texas MD Anderson Cancer Center)